Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel.

Praful PandeyAkash KumarDeepam PushpamSachin KhuranaPrabhat Singh MalikAjay GogiaElavarasi ArunmozhimaranMamta Bhushan SinghDinu Santha ChandranAtul Batra

Published in: Trials (2023)

The trial is registered prospectively with the Clinical Trials Registry of India (CTRI/2022/02/040030) on April 4, 2022.

Keyphrases

double blind
clinical trial
phase iii
placebo controlled
phase ii
study protocol
open label
neuropathic pain
randomized controlled trial
spinal cord injury
chemotherapy induced